These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10961443)

  • 21. Increased density of glutamate receptor subunit 1 due to Cerebrolysin treatment: an immunohistochemical study on aged rats.
    Eder P; Reinprecht I; Schreiner E; Skofitsch G; Windisch M
    Histochem J; 2001; 33(11-12):605-12. PubMed ID: 12197668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cerebrolysin treatment of mild cognitive impairment of vascular genesis].
    Damulin IV; Mkhitarian EA; Koberskaia NN
    Ter Arkh; 2007; 79(6):65-9. PubMed ID: 17684971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effects of cerebrolysin added to risperidone in patients with schizophrenia dominated by negative symptoms.
    Xiao S; Xue H; Li G; Yuan C; Li X; Chen C; Wu HZ; Mitchell P; Zhang M
    Aust N Z J Psychiatry; 2012 Feb; 46(2):153-60. PubMed ID: 22311531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders.
    Masliah E; Díez-Tejedor E
    Drugs Today (Barc); 2012 Apr; 48 Suppl A():3-24. PubMed ID: 22514792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrolysin in Alzheimer's disease.
    Antón Álvarez X; Fuentes P
    Drugs Today (Barc); 2011 Jul; 47(7):487-513. PubMed ID: 22013558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attention and Working Memory-Related EEG Markers of Subtle Cognitive Deterioration in Healthy Elderly Individuals.
    Deiber MP; Meziane HB; Hasler R; Rodriguez C; Toma S; Ackermann M; Herrmann F; Giannakopoulos P
    J Alzheimers Dis; 2015; 47(2):335-49. PubMed ID: 26401557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Citicoline improves memory performance in elderly subjects.
    Alvarez XA; Laredo M; Corzo D; Fernández-Novoa L; Mouzo R; Perea JE; Daniele D; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1997 Apr; 19(3):201-10. PubMed ID: 9203170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Cerebrolysin on in vitro primary microglial and astrocyte rat cell cultures.
    Lombardi VR; Windisch M; García M; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1999 Jun; 21(5):331-8. PubMed ID: 10420388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Electrophysiological correlates of efficacy of nootropic drugs in the treatment of consequences of traumatic brain injury in adolescents].
    Iznak EV; Iznak AF; Pankratova EA; Zavadenko NN; Guzilova LS; Guzilova IuI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 1):27-32. PubMed ID: 21322822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis: the efficacy of nootropic agent Cerebrolysin in the treatment of Alzheimer's disease.
    Wei ZH; He QB; Wang H; Su BH; Chen HZ
    J Neural Transm (Vienna); 2007; 114(5):629-34. PubMed ID: 17318304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal Cerebrolysin Attenuates Learning and Memory Impairments in D-galactose-Induced Senescence in Mice.
    Pourmemar E; Majdi A; Haramshahi M; Talebi M; Karimi P; Sadigh-Eteghad S
    Exp Gerontol; 2017 Jan; 87(Pt A):16-22. PubMed ID: 27894939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trophic effects of nootropic peptide preparations cerebrolysin and semax on cultured rat pheochromocytoma.
    Safarova ER; Shram SI; Grivennikov IA; Myasoedov NF
    Bull Exp Biol Med; 2002 Apr; 133(4):401-3. PubMed ID: 12124658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical experience with Cerebrolysin.
    Molloy DW; Standish TI
    J Neural Transm Suppl; 2000; 59():293-300. PubMed ID: 10961441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experience with using high doses of cerebrolysin in vascular dementia].
    Iakhno NN; Damulin IV; Zakharov VV; Levin OS; Elkin MN
    Ter Arkh; 1996; 68(10):65-9. PubMed ID: 9026950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin.
    Alvarez XA; Cacabelos R; Sampedro C; Aleixandre M; Linares C; Granizo E; Doppler E; Moessler H
    Eur J Neurol; 2011 Jan; 18(1):59-68. PubMed ID: 20500802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reductions in qEEG slowing over 1 year and after treatment with Cerebrolysin in patients with moderate-severe traumatic brain injury.
    Alvarez XA; Sampedro C; Figueroa J; Tellado I; González A; García-Fantini M; Cacabelos R; Muresanu D; Moessler H
    J Neural Transm (Vienna); 2008 May; 115(5):683-92. PubMed ID: 18273537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinguishing rhythmic from non-rhythmic brain activity during rest in healthy neurocognitive aging.
    Caplan JB; Bottomley M; Kang P; Dixon RA
    Neuroimage; 2015 May; 112():341-352. PubMed ID: 25769279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Event-related brain potentials and working memory function in healthy humans after single-dose and prolonged intranasal administration of adrenocorticotropin 4-10 and desacetyl-alpha-melanocyte stimulating hormone.
    Smolnik R; Perras B; Molle M; Fehm HL; Born J
    J Clin Psychopharmacol; 2000 Aug; 20(4):445-54. PubMed ID: 10917406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrolysin enhances functional recovery following focal cerebral infarction in rats.
    Ren J; Sietsma D; Qiu S; Moessler H; Finklestein SP
    Restor Neurol Neurosci; 2007; 25(1):25-31. PubMed ID: 17473393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ceruletide improves event-related potential indicators of cognitive processing in young but not in elderly humans.
    Dodt C; Sarnighausen HE; Pietrowsky R; Fehm HL; Born J
    J Clin Psychopharmacol; 1996 Dec; 16(6):440-5. PubMed ID: 8959469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.